Blog

Blog

FDA Update

FDA Update March 5, 2020 The U.S. Food and Drug Administration (“FDA” or “agency”) Commissioner Stephen Hahn M.D. recently issued a statement to update the public on the FDA’s work related to CBD products. The statement was released in conjunction with a formal report issued to Congress by the FDA to update Congress on their [...]

Packaging Design for CBD

Marketing a new product in the CBD industry is a challenge in itself, both for operators and marketers. Not only is each party faced with: blurred regulations when it comes to CBD packaging, carefully crafting the language on the packaging, the methods and channels of advertising, and of course the increasingly competitive nature of the [...]

CBD, and The SAFE Banking Act: Federal Banking Support and the CBD Industry.

2019 was an exciting year, when it comes to the world of CBD banking, and how CBD businesses can process transactions, store revenue, and utilize traditional banking systems in the United States. On Wednesday, September 25 2019, the House of Representatives passed the Secure and Fair Enforcement (SAFE) Banking Act. This bill is aimed at [...]

Is CBD Safe? An NPR Interview Review

Is CBD Safe? According to a recent NPR spot, “Use of CBD — cannabidiol, the non-psychoactive component in cannabis — has exploded in the last few years. But while it's marketed as a solution for stress, anxiety, insomnia, and pain, the Food and Drug Administration “can't” say it's safe.” In fact, the FDA has specifically [...]

FDA Approves Low-Nicotine Cigs, Overlooks Benefits of CBD

As we navigate the slow-changing landscape of CBD regulations, the CBD industry looks to the regulatory bodies that make these guidelines for answers on how to interact in the market. One big question we have is how is it, that after a 2017 announcement by the FDA to make cigarettes minimally or nonaddictive, it looks [...]

World Health Organization’s view of CBD

Questions about the health benefits of CBD continue to be debated. Depending on the source of the information,you will hear many positions. Currently, the United States Federal Drug Administration is working to study the effects in general of CBD in a number of products and applications. Namely, during the FDA review of Epidiolex, the prescription [...]